1. Home
  2. AMTB vs NEO Comparison

AMTB vs NEO Comparison

Compare AMTB & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amerant Bancorp Inc.

AMTB

Amerant Bancorp Inc.

HOLD

Current Price

$23.35

Market Cap

974.4M

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.92

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTB
NEO
Founded
1979
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
974.4M
1.0B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
AMTB
NEO
Price
$23.35
$8.92
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$23.67
$13.38
AVG Volume (30 Days)
234.8K
2.2M
Earning Date
04-23-2026
04-28-2026
Dividend Yield
1.57%
N/A
EPS Growth
386.36
N/A
EPS
0.44
N/A
Revenue
N/A
N/A
Revenue This Year
$8.29
$10.63
Revenue Next Year
$7.67
$9.73
P/E Ratio
$53.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.62
$4.72
52 Week High
$24.38
$13.74

Technical Indicators

Market Signals
Indicator
AMTB
NEO
Relative Strength Index (RSI) 55.82 55.41
Support Level $21.98 $7.50
Resistance Level $24.02 $10.66
Average True Range (ATR) 0.63 0.61
MACD -0.05 0.07
Stochastic Oscillator 68.97 48.11

Price Performance

Historical Comparison
AMTB
NEO

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: